Back to Search Start Over

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data.

Authors :
Chien HF
Rosso ALZ
Santos ASD
Rieder CRM
Maia DP
Silva DJD
Andrade MDC
Coletta MVD
Costa MDDLD
Allam N
Prado RCPD
Borges V
Tumas V
Horta WG
Source :
ENeurologicalSci [eNeurologicalSci] 2016 Jul 19; Vol. 5, pp. 11-14. Date of Electronic Publication: 2016 Jul 19 (Print Publication: 2016).
Publication Year :
2016

Abstract

Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients.

Details

Language :
English
ISSN :
2405-6502
Volume :
5
Database :
MEDLINE
Journal :
ENeurologicalSci
Publication Type :
Academic Journal
Accession number :
29430552
Full Text :
https://doi.org/10.1016/j.ensci.2016.07.001